1. Home
  2. CECO vs SLNO Comparison

CECO vs SLNO Comparison

Compare CECO & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CECO Environmental Corp.

CECO

CECO Environmental Corp.

HOLD

Current Price

$54.19

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$34.16

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CECO
SLNO
Founded
1966
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.3B
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
CECO
SLNO
Price
$54.19
$34.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$77.75
$108.00
AVG Volume (30 Days)
748.5K
1.3M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
280.56
108.90
EPS
1.37
0.39
Revenue
N/A
$1,450,788.00
Revenue This Year
$24.84
$155.44
Revenue Next Year
$11.51
$57.99
P/E Ratio
$39.62
$94.31
Revenue Growth
N/A
138.82
52 Week Low
$17.57
$32.63
52 Week High
$81.72
$89.12

Technical Indicators

Market Signals
Indicator
CECO
SLNO
Relative Strength Index (RSI) 36.02 32.76
Support Level $44.68 $32.63
Resistance Level $63.98 $44.60
Average True Range (ATR) 3.88 2.45
MACD -0.91 -0.18
Stochastic Oscillator 18.03 14.19

Price Performance

Historical Comparison
CECO
SLNO

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: